 | • レポートコード：MR2211MG10950 • 出版社/出版日：Market Monitor Global / 2022年11月 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（納期：2-3日） • 産業分類：医療 |
| Single User | ￥481,000 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥625,300 (USD4,225) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査資料は次の情報を含め、臨床体外診断サービスのグローバル市場規模と予測を記載しています。・臨床体外診断サービスのグローバル市場：売上、2017年-2022年、2023年-2028年 ・臨床体外診断サービスのグローバル市場：販売量、2017年-2022年、2023年-2028年 ・世界のトップ5企業、2021年 臨床体外診断サービスのグローバル市場規模は2021年に000Mドルと評価され、予測期間中に000％のCAGRで2028年までに000Mドルに達すると予測されています。米国市場は2021年に000Mドルと推定されており、中国は2028年までに000Mドルに達すると予測されています。「生化学診断」セグメントは今後6年間、000%のCAGRで2028年までに000Mドルに成長すると予測されています。 臨床体外診断サービスのグローバル主要企業は、Acibadem Labmed、 ACM Medical Laboratory、 American Bio-Clinical Laboratories、 American Pathology Partners、 ARUP Laboratories、 Bio-Reference Laboratories、 Bioscientia、 BP Healthcare Group、 Clongen Laboratories、 CompuNet、 Eurofins Scientific、 Exagen、 Innoquest Pathology、 Lifelabs、 Mayo Clinic Laboratories、 NeoGenomics、 OncoDNA、 Proなどです。2021年にトップ5企業がグローバル売上シェアの約000%を占めています。 マーケットモニターグローバル（MMG）社は、臨床体外診断サービスのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の臨床体外診断サービス市場：タイプ別、2017年-2022年、2023年-2028年 世界の臨床体外診断サービス市場：タイプ別市場シェア、2021年 ・生化学診断、免疫診断、分子診断、微生物診断、その他 世界の臨床体外診断サービス市場：用途別、2017年-2022年、2023年-2028年 世界の臨床体外診断サービス市場：用途別市場シェア、2021年 ・総合病院、専門クリニック 世界の臨床体外診断サービス市場：地域・国別、2017年-2022年、2023年-2028年 世界の臨床体外診断サービス市場：地域別市場シェア、2021年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における臨床体外診断サービスのグローバル売上、2017年-2022年 ・主要企業における臨床体外診断サービスのグローバル売上シェア、2021年 ・主要企業における臨床体外診断サービスのグローバル販売量、2017年-2022年 ・主要企業における臨床体外診断サービスのグローバル販売量シェア、2021年 さらに、当レポートは主要企業のプロファイルを提示します。 Acibadem Labmed、 ACM Medical Laboratory、 American Bio-Clinical Laboratories、 American Pathology Partners、 ARUP Laboratories、 Bio-Reference Laboratories、 Bioscientia、 BP Healthcare Group、 Clongen Laboratories、 CompuNet、 Eurofins Scientific、 Exagen、 Innoquest Pathology、 Lifelabs、 Mayo Clinic Laboratories、 NeoGenomics、 OncoDNA、 Pro ************************************************************* ・調査・分析レポートの概要 臨床体外診断サービス市場の定義 市場セグメント 世界の臨床体外診断サービス市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の臨床体外診断サービス市場規模 世界の臨床体外診断サービス市場規模：2021年 VS 2028年 世界の臨床体外診断サービス市場規模と予測 2017年-2028年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの臨床体外診断サービスの売上 グローバルトップ3およびトップ5企業、2021年売上ベース グローバル企業の臨床体外診断サービス製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：生化学診断、免疫診断、分子診断、微生物診断、その他 臨床体外診断サービスのタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：総合病院、専門クリニック 臨床体外診断サービスの用途別グローバル売上・予測 ・地域別市場分析 地域別臨床体外診断サービス市場規模 2021年と2028年 地域別臨床体外診断サービス売上・予測 北米市場 - アメリカの臨床体外診断サービス市場規模2017年-2028年 - カナダの臨床体外診断サービス市場規模2017年-2028年 - メキシコの臨床体外診断サービス市場規模2017年-2028年 ヨーロッパ市場 - ドイツの臨床体外診断サービス市場規模2017年-2028年 - フランスの臨床体外診断サービス市場規模2017年-2028年 - イギリスの臨床体外診断サービス市場規模2017年-2028年 - イタリアの臨床体外診断サービス市場規模2017年-2028年 - ロシアの臨床体外診断サービス市場規模2017年-2028年 アジア市場 - 中国の臨床体外診断サービス市場規模2017年-2028年 - 日本の臨床体外診断サービス市場規模2017年-2028年 - 韓国の臨床体外診断サービス市場規模2017年-2028年 - 東南アジアの臨床体外診断サービス市場規模2017年-2028年 - インドの臨床体外診断サービス市場規模2017年-2028年 南米市場 - ブラジルの臨床体外診断サービス市場規模2017年-2028年 - アルゼンチンの臨床体外診断サービス市場規模2017年-2028年 中東・アフリカ市場 - トルコの臨床体外診断サービス市場規模2017年-2028年 - イスラエルの臨床体外診断サービス市場規模2017年-2028年 - サウジアラビアの臨床体外診断サービス市場規模2017年-2028年 - UAEの臨床体外診断サービス市場規模2017年-2028年 ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Acibadem Labmed、 ACM Medical Laboratory、 American Bio-Clinical Laboratories、 American Pathology Partners、 ARUP Laboratories、 Bio-Reference Laboratories、 Bioscientia、 BP Healthcare Group、 Clongen Laboratories、 CompuNet、 Eurofins Scientific、 Exagen、 Innoquest Pathology、 Lifelabs、 Mayo Clinic Laboratories、 NeoGenomics、 OncoDNA、 Pro ... |
This report contains market size and forecasts of Clinical in Vitro Diagnostic Service in Global, including the following market information:
Global Clinical in Vitro Diagnostic Service Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Clinical in Vitro Diagnostic Service market was valued at US$ million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Biochemical Diagnostics Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Clinical in Vitro Diagnostic Service include Acibadem Labmed, ACM Medical Laboratory, American Bio-Clinical Laboratories, American Pathology Partners, ARUP Laboratories, Bio-Reference Laboratories, Bioscientia, BP Healthcare Group and Clongen Laboratories, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Clinical in Vitro Diagnostic Service companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Clinical in Vitro Diagnostic Service Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Clinical in Vitro Diagnostic Service Market Segment Percentages, by Type, 2021 (%)
Biochemical Diagnostics
ImmunoDiagnostics
Molecular Diagnostics
Microbiological Diagnostics
Others
Global Clinical in Vitro Diagnostic Service Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Clinical in Vitro Diagnostic Service Market Segment Percentages, by Application, 2021 (%)
General Hospitals
Specialty Clinics
Global Clinical in Vitro Diagnostic Service Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Clinical in Vitro Diagnostic Service Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Clinical in Vitro Diagnostic Service revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Clinical in Vitro Diagnostic Service revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Acibadem Labmed
ACM Medical Laboratory
American Bio-Clinical Laboratories
American Pathology Partners
ARUP Laboratories
Bio-Reference Laboratories
Bioscientia
BP Healthcare Group
Clongen Laboratories
CompuNet
Eurofins Scientific
Exagen
Innoquest Pathology
Lifelabs
Mayo Clinic Laboratories
NeoGenomics
OncoDNA
ProPhase Labs
Psychemedics
Quest Diagnostics
RDL Reference Laboratory
Sonic Healthcare
Spectra Laboratories
Sysmex Inostics
Unilabs
1 Introduction to Research & Analysis Reports
1.1 Clinical in Vitro Diagnostic Service Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Clinical in Vitro Diagnostic Service Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Clinical in Vitro Diagnostic Service Overall Market Size
2.1 Global Clinical in Vitro Diagnostic Service Market Size: 2021 VS 2028
2.2 Global Clinical in Vitro Diagnostic Service Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Clinical in Vitro Diagnostic Service Players in Global Market
3.2 Top Global Clinical in Vitro Diagnostic Service Companies Ranked by Revenue
3.3 Global Clinical in Vitro Diagnostic Service Revenue by Companies
3.4 Top 3 and Top 5 Clinical in Vitro Diagnostic Service Companies in Global Market, by Revenue in 2021
3.5 Global Companies Clinical in Vitro Diagnostic Service Product Type
3.6 Tier 1, Tier 2 and Tier 3 Clinical in Vitro Diagnostic Service Players in Global Market
3.6.1 List of Global Tier 1 Clinical in Vitro Diagnostic Service Companies
3.6.2 List of Global Tier 2 and Tier 3 Clinical in Vitro Diagnostic Service Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type – Global Clinical in Vitro Diagnostic Service Market Size Markets, 2021 & 2028
4.1.2 Biochemical Diagnostics
4.1.3 ImmunoDiagnostics
4.1.4 Molecular Diagnostics
4.1.5 Microbiological Diagnostics
4.1.6 Others
4.2 By Type – Global Clinical in Vitro Diagnostic Service Revenue & Forecasts
4.2.1 By Type – Global Clinical in Vitro Diagnostic Service Revenue, 2017-2022
4.2.2 By Type – Global Clinical in Vitro Diagnostic Service Revenue, 2023-2028
4.2.3 By Type – Global Clinical in Vitro Diagnostic Service Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Clinical in Vitro Diagnostic Service Market Size, 2021 & 2028
5.1.2 General Hospitals
5.1.3 Specialty Clinics
5.2 By Application – Global Clinical in Vitro Diagnostic Service Revenue & Forecasts
5.2.1 By Application – Global Clinical in Vitro Diagnostic Service Revenue, 2017-2022
5.2.2 By Application – Global Clinical in Vitro Diagnostic Service Revenue, 2023-2028
5.2.3 By Application – Global Clinical in Vitro Diagnostic Service Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region – Global Clinical in Vitro Diagnostic Service Market Size, 2021 & 2028
6.2 By Region – Global Clinical in Vitro Diagnostic Service Revenue & Forecasts
6.2.1 By Region – Global Clinical in Vitro Diagnostic Service Revenue, 2017-2022
6.2.2 By Region – Global Clinical in Vitro Diagnostic Service Revenue, 2023-2028
6.2.3 By Region – Global Clinical in Vitro Diagnostic Service Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country – North America Clinical in Vitro Diagnostic Service Revenue, 2017-2028
6.3.2 US Clinical in Vitro Diagnostic Service Market Size, 2017-2028
6.3.3 Canada Clinical in Vitro Diagnostic Service Market Size, 2017-2028
6.3.4 Mexico Clinical in Vitro Diagnostic Service Market Size, 2017-2028
6.4 Europe
6.4.1 By Country – Europe Clinical in Vitro Diagnostic Service Revenue, 2017-2028
6.4.2 Germany Clinical in Vitro Diagnostic Service Market Size, 2017-2028
6.4.3 France Clinical in Vitro Diagnostic Service Market Size, 2017-2028
6.4.4 U.K. Clinical in Vitro Diagnostic Service Market Size, 2017-2028
6.4.5 Italy Clinical in Vitro Diagnostic Service Market Size, 2017-2028
6.4.6 Russia Clinical in Vitro Diagnostic Service Market Size, 2017-2028
6.4.7 Nordic Countries Clinical in Vitro Diagnostic Service Market Size, 2017-2028
6.4.8 Benelux Clinical in Vitro Diagnostic Service Market Size, 2017-2028
6.5 Asia
6.5.1 By Region – Asia Clinical in Vitro Diagnostic Service Revenue, 2017-2028
6.5.2 China Clinical in Vitro Diagnostic Service Market Size, 2017-2028
6.5.3 Japan Clinical in Vitro Diagnostic Service Market Size, 2017-2028
6.5.4 South Korea Clinical in Vitro Diagnostic Service Market Size, 2017-2028
6.5.5 Southeast Asia Clinical in Vitro Diagnostic Service Market Size, 2017-2028
6.5.6 India Clinical in Vitro Diagnostic Service Market Size, 2017-2028
6.6 South America
6.6.1 By Country – South America Clinical in Vitro Diagnostic Service Revenue, 2017-2028
6.6.2 Brazil Clinical in Vitro Diagnostic Service Market Size, 2017-2028
6.6.3 Argentina Clinical in Vitro Diagnostic Service Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Clinical in Vitro Diagnostic Service Revenue, 2017-2028
6.7.2 Turkey Clinical in Vitro Diagnostic Service Market Size, 2017-2028
6.7.3 Israel Clinical in Vitro Diagnostic Service Market Size, 2017-2028
6.7.4 Saudi Arabia Clinical in Vitro Diagnostic Service Market Size, 2017-2028
6.7.5 UAE Clinical in Vitro Diagnostic Service Market Size, 2017-2028
7 Players Profiles
7.1 Acibadem Labmed
7.1.1 Acibadem Labmed Corporate Summary
7.1.2 Acibadem Labmed Business Overview
7.1.3 Acibadem Labmed Clinical in Vitro Diagnostic Service Major Product Offerings
7.1.4 Acibadem Labmed Clinical in Vitro Diagnostic Service Revenue in Global Market (2017-2022)
7.1.5 Acibadem Labmed Key News
7.2 ACM Medical Laboratory
7.2.1 ACM Medical Laboratory Corporate Summary
7.2.2 ACM Medical Laboratory Business Overview
7.2.3 ACM Medical Laboratory Clinical in Vitro Diagnostic Service Major Product Offerings
7.2.4 ACM Medical Laboratory Clinical in Vitro Diagnostic Service Revenue in Global Market (2017-2022)
7.2.5 ACM Medical Laboratory Key News
7.3 American Bio-Clinical Laboratories
7.3.1 American Bio-Clinical Laboratories Corporate Summary
7.3.2 American Bio-Clinical Laboratories Business Overview
7.3.3 American Bio-Clinical Laboratories Clinical in Vitro Diagnostic Service Major Product Offerings
7.3.4 American Bio-Clinical Laboratories Clinical in Vitro Diagnostic Service Revenue in Global Market (2017-2022)
7.3.5 American Bio-Clinical Laboratories Key News
7.4 American Pathology Partners
7.4.1 American Pathology Partners Corporate Summary
7.4.2 American Pathology Partners Business Overview
7.4.3 American Pathology Partners Clinical in Vitro Diagnostic Service Major Product Offerings
7.4.4 American Pathology Partners Clinical in Vitro Diagnostic Service Revenue in Global Market (2017-2022)
7.4.5 American Pathology Partners Key News
7.5 ARUP Laboratories
7.5.1 ARUP Laboratories Corporate Summary
7.5.2 ARUP Laboratories Business Overview
7.5.3 ARUP Laboratories Clinical in Vitro Diagnostic Service Major Product Offerings
7.5.4 ARUP Laboratories Clinical in Vitro Diagnostic Service Revenue in Global Market (2017-2022)
7.5.5 ARUP Laboratories Key News
7.6 Bio-Reference Laboratories
7.6.1 Bio-Reference Laboratories Corporate Summary
7.6.2 Bio-Reference Laboratories Business Overview
7.6.3 Bio-Reference Laboratories Clinical in Vitro Diagnostic Service Major Product Offerings
7.6.4 Bio-Reference Laboratories Clinical in Vitro Diagnostic Service Revenue in Global Market (2017-2022)
7.6.5 Bio-Reference Laboratories Key News
7.7 Bioscientia
7.7.1 Bioscientia Corporate Summary
7.7.2 Bioscientia Business Overview
7.7.3 Bioscientia Clinical in Vitro Diagnostic Service Major Product Offerings
7.7.4 Bioscientia Clinical in Vitro Diagnostic Service Revenue in Global Market (2017-2022)
7.7.5 Bioscientia Key News
7.8 BP Healthcare Group
7.8.1 BP Healthcare Group Corporate Summary
7.8.2 BP Healthcare Group Business Overview
7.8.3 BP Healthcare Group Clinical in Vitro Diagnostic Service Major Product Offerings
7.8.4 BP Healthcare Group Clinical in Vitro Diagnostic Service Revenue in Global Market (2017-2022)
7.8.5 BP Healthcare Group Key News
7.9 Clongen Laboratories
7.9.1 Clongen Laboratories Corporate Summary
7.9.2 Clongen Laboratories Business Overview
7.9.3 Clongen Laboratories Clinical in Vitro Diagnostic Service Major Product Offerings
7.9.4 Clongen Laboratories Clinical in Vitro Diagnostic Service Revenue in Global Market (2017-2022)
7.9.5 Clongen Laboratories Key News
7.10 CompuNet
7.10.1 CompuNet Corporate Summary
7.10.2 CompuNet Business Overview
7.10.3 CompuNet Clinical in Vitro Diagnostic Service Major Product Offerings
7.10.4 CompuNet Clinical in Vitro Diagnostic Service Revenue in Global Market (2017-2022)
7.10.5 CompuNet Key News
7.11 Eurofins Scientific
7.11.1 Eurofins Scientific Corporate Summary
7.11.2 Eurofins Scientific Business Overview
7.11.3 Eurofins Scientific Clinical in Vitro Diagnostic Service Major Product Offerings
7.11.4 Eurofins Scientific Clinical in Vitro Diagnostic Service Revenue in Global Market (2017-2022)
7.11.5 Eurofins Scientific Key News
7.12 Exagen
7.12.1 Exagen Corporate Summary
7.12.2 Exagen Business Overview
7.12.3 Exagen Clinical in Vitro Diagnostic Service Major Product Offerings
7.12.4 Exagen Clinical in Vitro Diagnostic Service Revenue in Global Market (2017-2022)
7.12.5 Exagen Key News
7.13 Innoquest Pathology
7.13.1 Innoquest Pathology Corporate Summary
7.13.2 Innoquest Pathology Business Overview
7.13.3 Innoquest Pathology Clinical in Vitro Diagnostic Service Major Product Offerings
7.13.4 Innoquest Pathology Clinical in Vitro Diagnostic Service Revenue in Global Market (2017-2022)
7.13.5 Innoquest Pathology Key News
7.14 Lifelabs
7.14.1 Lifelabs Corporate Summary
7.14.2 Lifelabs Business Overview
7.14.3 Lifelabs Clinical in Vitro Diagnostic Service Major Product Offerings
7.14.4 Lifelabs Clinical in Vitro Diagnostic Service Revenue in Global Market (2017-2022)
7.14.5 Lifelabs Key News
7.15 Mayo Clinic Laboratories
7.15.1 Mayo Clinic Laboratories Corporate Summary
7.15.2 Mayo Clinic Laboratories Business Overview
7.15.3 Mayo Clinic Laboratories Clinical in Vitro Diagnostic Service Major Product Offerings
7.15.4 Mayo Clinic Laboratories Clinical in Vitro Diagnostic Service Revenue in Global Market (2017-2022)
7.15.5 Mayo Clinic Laboratories Key News
7.16 NeoGenomics
7.16.1 NeoGenomics Corporate Summary
7.16.2 NeoGenomics Business Overview
7.16.3 NeoGenomics Clinical in Vitro Diagnostic Service Major Product Offerings
7.16.4 NeoGenomics Clinical in Vitro Diagnostic Service Revenue in Global Market (2017-2022)
7.16.5 NeoGenomics Key News
7.17 OncoDNA
7.17.1 OncoDNA Corporate Summary
7.17.2 OncoDNA Business Overview
7.17.3 OncoDNA Clinical in Vitro Diagnostic Service Major Product Offerings
7.17.4 OncoDNA Clinical in Vitro Diagnostic Service Revenue in Global Market (2017-2022)
7.17.5 OncoDNA Key News
7.18 ProPhase Labs
7.18.1 ProPhase Labs Corporate Summary
7.18.2 ProPhase Labs Business Overview
7.18.3 ProPhase Labs Clinical in Vitro Diagnostic Service Major Product Offerings
7.18.4 ProPhase Labs Clinical in Vitro Diagnostic Service Revenue in Global Market (2017-2022)
7.18.5 ProPhase Labs Key News
7.19 Psychemedics
7.19.1 Psychemedics Corporate Summary
7.19.2 Psychemedics Business Overview
7.19.3 Psychemedics Clinical in Vitro Diagnostic Service Major Product Offerings
7.19.4 Psychemedics Clinical in Vitro Diagnostic Service Revenue in Global Market (2017-2022)
7.19.5 Psychemedics Key News
7.20 Quest Diagnostics
7.20.1 Quest Diagnostics Corporate Summary
7.20.2 Quest Diagnostics Business Overview
7.20.3 Quest Diagnostics Clinical in Vitro Diagnostic Service Major Product Offerings
7.20.4 Quest Diagnostics Clinical in Vitro Diagnostic Service Revenue in Global Market (2017-2022)
7.20.5 Quest Diagnostics Key News
7.21 RDL Reference Laboratory
7.21.1 RDL Reference Laboratory Corporate Summary
7.21.2 RDL Reference Laboratory Business Overview
7.21.3 RDL Reference Laboratory Clinical in Vitro Diagnostic Service Major Product Offerings
7.21.4 RDL Reference Laboratory Clinical in Vitro Diagnostic Service Revenue in Global Market (2017-2022)
7.21.5 RDL Reference Laboratory Key News
7.22 Sonic Healthcare
7.22.1 Sonic Healthcare Corporate Summary
7.22.2 Sonic Healthcare Business Overview
7.22.3 Sonic Healthcare Clinical in Vitro Diagnostic Service Major Product Offerings
7.22.4 Sonic Healthcare Clinical in Vitro Diagnostic Service Revenue in Global Market (2017-2022)
7.22.5 Sonic Healthcare Key News
7.23 Spectra Laboratories
7.23.1 Spectra Laboratories Corporate Summary
7.23.2 Spectra Laboratories Business Overview
7.23.3 Spectra Laboratories Clinical in Vitro Diagnostic Service Major Product Offerings
7.23.4 Spectra Laboratories Clinical in Vitro Diagnostic Service Revenue in Global Market (2017-2022)
7.23.5 Spectra Laboratories Key News
7.24 Sysmex Inostics
7.24.1 Sysmex Inostics Corporate Summary
7.24.2 Sysmex Inostics Business Overview
7.24.3 Sysmex Inostics Clinical in Vitro Diagnostic Service Major Product Offerings
7.24.4 Sysmex Inostics Clinical in Vitro Diagnostic Service Revenue in Global Market (2017-2022)
7.24.5 Sysmex Inostics Key News
7.25 Unilabs
7.25.1 Unilabs Corporate Summary
7.25.2 Unilabs Business Overview
7.25.3 Unilabs Clinical in Vitro Diagnostic Service Major Product Offerings
7.25.4 Unilabs Clinical in Vitro Diagnostic Service Revenue in Global Market (2017-2022)
7.25.5 Unilabs Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer